Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms
Authors
Keywords
Cervical cancer, miR-486-5p, Pten, PI3K/Akt
Journal
BMC CANCER
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-01-09
DOI
10.1186/s12885-017-3753-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MicroRNAs are involved in cervical cancer development, progression, clinical outcome and improvement treatment response (Review)
- (2015) VÍCTOR GONZÁLEZ-QUINTANA et al. ONCOLOGY REPORTS
- The Global Burden of Cancer 2013
- (2015) Christina Fitzmaurice et al. JAMA Oncology
- Expression and Prognostic Value of miR-486-5p in Patients with Gastric Adenocarcinoma
- (2015) Hui Chen et al. PLoS One
- MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer
- (2015) Wanshuai Li et al. PLoS One
- MicroRNA-486-5p is an erythroid oncomiR of the myeloid leukemias of Down syndrome
- (2014) L. Shaham et al. BLOOD
- MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors
- (2014) L.-S. Wang et al. BLOOD
- MicroRNA-486–dependent modulation of DOCK3/PTEN/AKT signaling pathways improves muscular dystrophy–associated symptoms
- (2014) Matthew S. Alexander et al. JOURNAL OF CLINICAL INVESTIGATION
- Down-Regulation of mir-221 and mir-222 Restrain Prostate Cancer Cell Proliferation and Migration That Is Partly Mediated by Activation of SIRT1
- (2014) Xiao Yang et al. PLoS One
- Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer
- (2013) J Wang et al. ONCOGENE
- Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486
- (2012) Jing Xu et al. KIDNEY INTERNATIONAL
- MicroRNA profiling in cancer: Table 1
- (2011) Reinhold Munker et al. CLINICAL SCIENCE
- MicroRNA history: Discovery, recent applications, and next frontiers
- (2011) Maria I. Almeida et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- MicroRNAs in body fluids—the mix of hormones and biomarkers
- (2011) Maria Angelica Cortez et al. Nature Reviews Clinical Oncology
- The widespread regulation of microRNA biogenesis, function and decay
- (2010) Jacek Krol et al. NATURE REVIEWS GENETICS
- Roles of small RNAs in tumor formation
- (2010) Gianpiero Di Leva et al. TRENDS IN MOLECULAR MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started